AAAAAA

   
Results: 1-10 |
Results: 10
Human papillomavirus-16-E7 oncoprotein enhances the expression of adhesionmolecules in cervical endothelial cells but not in human umbilical vein endothelial cells
Authors: D'Anna, R Le Buanec, H Bizzini, B Burny, A Giannouli, C Zagury, JF Gallo, RC Zagury, D D'Alessio, P
Citation: R. D'Anna et al., Human papillomavirus-16-E7 oncoprotein enhances the expression of adhesionmolecules in cervical endothelial cells but not in human umbilical vein endothelial cells, J HUMAN VIR, 4(2), 2001, pp. 85-95
Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes
Authors: Le Buanec, H Vetu, C Lachgar, A Benoit, MA Gillard, J Paturance, S Aucouturier, J Gane, V Zagury, D Bizzini, B
Citation: H. Le Buanec et al., Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes, BIOMED PHAR, 55(6), 2001, pp. 316-320
Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat Toroid) for human use
Authors: Le Buanec, H Bizzini, B
Citation: H. Le Buanec et B. Bizzini, Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat Toroid) for human use, BIOMED PHAR, 54(1), 2000, pp. 41-44
Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques
Authors: Pauza, CD Trivedi, P Wallace, M Ruckwardt, TJ Le Buanec, H Lu, W Bizzini, B Burny, A Zagury, D Gallo, RC
Citation: Cd. Pauza et al., Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques, P NAS US, 97(7), 2000, pp. 3515-3519
Tat toxoid as a component of a preventive vaccine in seronegative subjects
Authors: Gringeri, A Santagostino, E Muca-Perja, M Le Buanec, H Bizzini, B Lachgar, A Zagury, JF Rappaport, J Burny, A Gallo, RC Zagury, D
Citation: A. Gringeri et al., Tat toxoid as a component of a preventive vaccine in seronegative subjects, J ACQ IMM D, 20(4), 1999, pp. 371-375
HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes
Authors: Le Buanec, H D'Anna, R Lachgar, A Zagury, JF Bernard, J Ittele, D d'Alessio, P Hallez, S Giannouli, C Burny, A Bizzini, B Gallo, RC Zagury, D
Citation: H. Le Buanec et al., HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes, BIOMED PHAR, 53(9), 1999, pp. 424-431
Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein
Authors: Le Buanec, H Lachgar, A D'Anna, R Zagury, JF Bizzini, B Bernard, J Ittele, D Hallez, S Giannouli, C Burny, A Zagury, D
Citation: H. Le Buanec et al., Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein, BIOMED PHAR, 53(7), 1999, pp. 323-328
Lectin production by human T-lymphocytes
Authors: Lachgar, A Le Buanec, H Burny, A Bizzini, B Zagury, D
Citation: A. Lachgar et al., Lectin production by human T-lymphocytes, BIOMED PHAR, 53(5-6), 1999, pp. 288-289
Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum - an adjuvant to antiretroviral tritherapy
Authors: Zagury, D Lecoq, H Gervi, I Le Buanec, H Zagury, JF Bizzini, B Burny, A Hermans, P Perja, M Santagostino, E Gringeri, A
Citation: D. Zagury et al., Anti-IFN alpha immunization raises the IFN alpha-neutralizing capacity of serum - an adjuvant to antiretroviral tritherapy, BIOMED PHAR, 53(2), 1999, pp. 90-92
A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat Toxoid
Authors: Le Buanec, H Lachgar, A Bizzini, B Zagury, JF Rappaport, J Santagostino, E Muca-Perja, M Gringeri, A
Citation: H. Le Buanec et al., A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat Toxoid, BIOMED PHAR, 52(10), 1998, pp. 431-435
Risultati: 1-10 |